Vassilis E. Papadopoulos

Modulation of &bgr;-glucocerebrosidase increases &agr;-synuclein secretion and exosome release in mouse models of Parkinson’s disease

S. Sardi, L. Stefanis, Evangelia Emmanouilidou, 2018, Human molecular genetics.

Neurolisteriosis in a previously asymptomatic patient with serum IgM deficiency: a case report

K. Patas, S. Chatzipanagiotou, G. Mandilara, 2020, BMC Neurology.

Gerstmann syndrome as a disconnection syndrome, evidence from DTI tractography: A case report

M. Angelopoulou, F. Christidi, E. Karavasilis, 2021, Journal of Neurolinguistics.

MRI evidence of extraocular muscle atrophy and fatty replacement in myasthenia gravis

E. Karavasilis, G. Velonakis, D. Filippiadis, 2021, Neuroradiology.

Seronegative Neurobrucellosis - Do we need new Neurobrucellosis criteria?

G. Velonakis, K. Patas, A. Tountopoulou, 2021, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Comprehensive Evaluation of Psychotic Features and Their Clinical Correlates in Early Parkinson’s Disease

N. Scarmeas, S. Papageorgiou, I. Pachi, 2023, Journal of Parkinson's disease.

Jumping to conclusions bias, psychosis and impulsivity in early stages of Parkinson’s disease

N. Scarmeas, K. Kollias, C. Potagas, 2023, Journal of Neurology.

Association of B-cell activating factor gene variants with serum anti-JCV antibody positivity in male patients with multiple sclerosis under natalizumab treatment: Implications for progressive multifocal leukoencephalopathy risk stratification

C. Mavragani, Charalampos Skarlis, M. Evangelopoulos, 2024, Journal of the Neurological Sciences.

B-cell activating factor gene variants in multiple sclerosis: Possible associations with disease susceptibility among females.

C. Mavragani, Charalampos Skarlis, M. Evangelopoulos, 2023, Clinical immunology.